# Disruption of estrogen signaling by developmental exposure to BPA and TBT causes long term functional deficits in zebrafish retina

**Authors:** J. S. Jensen, L. Ouellette, R. Harris, P. Owrang, V. P. Connaughton

PMC · DOI: 10.3389/fphar.2026.1750796 · Frontiers in Pharmacology · 2026-02-17

## TL;DR

Exposure to BPA and TBT during development disrupts estrogen signaling in zebrafish retinas, leading to long-term visual system deficits.

## Contribution

The study reveals that BPA and TBT, despite opposing effects on estrogen signaling, cause similar long-term retinal dysfunction in zebrafish.

## Key findings

- Developmental exposure to BPA and TBT leads to persistent retinal functional deficits in adult zebrafish.
- Both compounds affect retinal development despite having opposite mechanisms of action on estrogen signaling.
- The effects of exposure vary with concentration and age, suggesting complex interactions beyond estrogenic modulation.

## Abstract

Bisphenol A (BPA) and tributyltin (TBT) are two endocrine disrupting compounds (EDC) that have opposite effects on estrogen signaling. BPA is an estrogen agonist that binds to all estrogen receptor types. TBT is an aromatase inhibitor that binds to the enzyme aromatase, preventing the synthesis of estrogen from testosterone. Both estrogen receptors and aromatase are localized to the retina and estrogen signaling is required for proper eye and retinal neurogenesis. Abnormal eye growth and retinal changes are reported immediately after developmental exposure to either EDC consistent with the role of estrogen in proper neurogenesis. In this review, we examine the impact of BPA and TBT exposure on the development and function of the visual system. We focus primarily on zebrafish but include data from other species to show trends across vertebrates. We discuss a case study designed to determine if a transient developmental exposure to BPA or TBT has persistent effects that are evident in adults and if these latent outcomes reflect the opposite impact of these compounds on estrogen signaling. Surprisingly, although some opposing outcomes were observed, most differences in adult retinal function were similar between the two compounds, with varying effects noted by concentration and exposure age. Overall, we conclude that developing zebrafish retina is sensitive to EDCs that target estrogenic pathways. However, these findings cannot be explained by estrogenic modulation alone, suggesting additional mechanisms beyond their current established roles.

## Linked entities

- **Proteins:** Cyp19a1 (cytochrome P450, family 19, subfamily a, polypeptide 1)
- **Chemicals:** Bisphenol A (PubChem CID 6623), BPA (PubChem CID 6623), tributyltin (PubChem CID 5948)
- **Species:** Danio rerio (taxon 7955)

## Full-text entities

- **Genes:** erg (ETS transcription factor ERG) [NCBI Gene 494073] {aka zgc:103429}, Gper1 (G protein-coupled estrogen receptor 1) [NCBI Gene 76854] {aka 6330420K13Rik, CMKRL2, Ceprl, FEG-1, GPCR-Br, Gper}, Cyp19a1 (cytochrome P450, family 19, subfamily a, polypeptide 1) [NCBI Gene 13075] {aka Ar, ArKO, Cyp19, Int-5, Int5, p450arom}, Esr2 (estrogen receptor 2 (beta)) [NCBI Gene 13983] {aka ER[b], ERbeta, Estrb}, esr2a (estrogen receptor 2a) [NCBI Gene 317734] {aka ER[b]2, ER[b]a, abrrl5, zfER-beta2, zfER[b]2}, cyp19a1a (cytochrome P450, family 19, subfamily A, polypeptide 1a) [NCBI Gene 30390] {aka CYP19a1, P450aromA, ar1, cyp19, cyp19a, cypXIX}, esr2b (estrogen receptor 2b) [NCBI Gene 317733] {aka ER[b]1, abrrl6, zfER-beta1, zfER[b]1}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 26419] {aka JNK, JNK1, Prkm8, SAPK1}, cyp19a1b (cytochrome P450, family 19, subfamily A, polypeptide 1b) [NCBI Gene 60640] {aka AroB, CYP19a2, P450aromB, cyp19, cyp19b, zgc:92614}, ESR2 (estrogen receptor 2) [NCBI Gene 2100] {aka ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2}, mapk8b (mitogen-activated protein kinase 8b) [NCBI Gene 65236] {aka JNK, JNK1, jnk1a-1, jnk1b, mapk8, zgc:112379}, GPER1 (G protein-coupled estrogen receptor 1) [NCBI Gene 2852] {aka CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER}, ttr (transthyretin (prealbumin, amyloidosis type I)) [NCBI Gene 449556] {aka zgc:103583}, thrb (thyroid hormone receptor beta) [NCBI Gene 30607] {aka NR1A2, TR-beta, TR[b]1, fj24f03, thr2, trb}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, Esr1 (estrogen receptor 1 (alpha)) [NCBI Gene 13982] {aka ER, ER-alpha, ERa, ERalpha, ESR, Estr}, gad1b (glutamate decarboxylase 1b) [NCBI Gene 378441] {aka GAD67, gad1}, gper1 (G protein-coupled estrogen receptor 1) [NCBI Gene 565271] {aka gper, gpr30}, esr1 (estrogen receptor 1) [NCBI Gene 259252] {aka ER[a], ESR, NR3A1, abrrl, eralpha, zfER[a]}, th (tyrosine hydroxylase) [NCBI Gene 30384], Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}
- **Diseases:** retinopathy (MESH:D058437), hypoxia (MESH:D000860), reproductive tract abnormalities (MESH:D060737), visual deficits (MESH:D014786), inflammatory (MESH:D007249), complications (MESH:D008107), metabolic disturbances (MESH:D024821), anxiety (MESH:D001007), behavior (MESH:D001523), neurotoxicity (MESH:D020258), cancers (MESH:D009369), neurodegenerative retinal diseases (MESH:D012164), estrogenic (MESH:D056828), INL (MESH:D007759), depression (MESH:D003866), breast cancer (MESH:D001943), crush (MESH:D003444), metabolic, reproductive, and neurological disorders (MESH:D001928), toxicity (MESH:D064420), preterm births (MESH:D047928), cardiovascular problems (MESH:D002318), and delayed (MESH:D006968), placental abnormalities (MESH:D010922), EDCs (MESH:D004700)
- **Chemicals:** testosterone (MESH:D013739), BPA (MESH:C006780), water (MESH:D014867), ethanol (MESH:D000431), cholesterol (MESH:D002784), GABA (MESH:D005680), NMDA (MESH:D016202), Sn (MESH:D014001), TTX (MESH:D013779), glutamate (MESH:D018698), BPA-glucuronide (MESH:C512161), TPT (MESH:C030665), 17beta-estradiol (MESH:D004958), androstenedione (MESH:D000735), lipid (MESH:D008055), PCB47 (MESH:C035976), serotonin (MESH:D012701), organotin (MESH:D009947), glucose (MESH:D005947), DMSO (MESH:D004121), 4-OH-A (MESH:C014594), EDCs (MESH:C024565), calcium (MESH:D002118), Dopamine (MESH:D004298), K+ (MESH:D011188), TBT (MESH:C011559), Na+ (MESH:D012964), PCB (MESH:D011078), T4 (MESH:D013974), Ca+2 (-), PCB77 (MESH:C028451), H&amp;E (MESH:D006371), estriol (MESH:D004964), TBBPA (MESH:C020806), phenylalanine (MESH:D010649), epoxy resin (MESH:D004853), PVC (MESH:D011143), TMT (MESH:C046488)
- **Species:** Carassius auratus (goldfish, species) [taxon 7957], Mus musculus (house mouse, species) [taxon 10090], Xenopus laevis (African clawed frog, species) [taxon 8355], Oryzias latipes (Japanese medaka, species) [taxon 8090], Danio rerio (leopard danio, species) [taxon 7955], Pelates octolineatus (eight-lined trumpeter, species) [taxon 886300], Rodentia (rodent, order) [taxon 9989], Salmo salar (Atlantic salmon, species) [taxon 8030], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** P13K
- **Cell lines:** CA3 — Homo sapiens (Human), Acanthosis nigricans, Cancer cell line (CVCL_0028), GH3 — Rattus norvegicus (Rat), Rat pituitary gland neoplasm, Cancer cell line (CVCL_0273), 293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12953471/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12953471/full.md

## References

231 references — full list in the complete paper: https://tomesphere.com/paper/PMC12953471/full.md

---
Source: https://tomesphere.com/paper/PMC12953471